Mainstream

MEI Pharma soars after $100M litecoin treasury move, first public LTC holder on U.S. exchange

MEI Pharma soars after $100M litecoin treasury move, first public LTC holder on U.S. exchange

Post Contentmeip, ltc-usdRead More

You might also be interested in reading Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD.

July 18, 2025
In Mainstream